Jeanette M. Pots

Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells

Gerty Schreibelt, Kalijn F. Bol, Harm Westdorp et al. · Clinical Cancer Research · 2015 · 231 citations

Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN

Luis J. Cruz, Paul J. Tacken, Jeanette M. Pots et al. · Biomaterials · 2012 · 77 citations

Vaccination, Human Dendritic Cells, Vaccine Development +9

Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients

Kalijn F. Bol, Carl G. Figdor, Erik H.J.G. Aarntzen et al. · OncoImmunology · 2015 · 66 citations · Full text

Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity

Kalijn F. Bol, Erik H.J.G. Aarntzen, Jeanette M. Pots et al. · Cancer Immunology Immunotherapy · 2016 · 65 citations · Full text

Cytokine analysis as a tool to understand tumour–host interaction in ovarian cancer

Refika Yigit, Carl G. Figdor, Petra L.M. Zusterzeel et al. · European Journal of Cancer · 2011 · 56 citations

Cancer Immunosurveillance, Medicine, Cytokine Analysis +9